4/28/2016
![](https://cdn.orano.group/arevasa/News/images/CP_groupe/CP-2016/CP-CAT12016-EN-500px.png)
-----------------------------------------------
1 Restated for IFRS 5
2 Includes the Corporate, AREVA Med, Bioenergy operations and the OL3 project
Contact
Contact
- Press Office:
Tel: +33 1 34 96 12 15
press@areva.com - Investors Relations:
Manuel Lachaux
manuel.lachaux@areva.com
T : +33 (0)1 34 96 11 53
Anne-Sophie Jugean
anne-sophie.jugean@areva.com
T : +33 (0)1 34 96 62 41 -
AREVAfr